March 27, 2023

To whom it may concern

Company: Teijin Limited

Representative: Akimoto Uchikawa, President and CEO Stock code: 3401 (Prime Market, Tokyo Stock Exchange)

Contact: Tomoya Yoshitomi, General Manager,

Investor and Public Relations Department

TEL: +81-3-3506-4395

Notice Regarding Dividends Received from Consolidated Subsidiaries

Teijin Limited (hereinafter, the "Company") today received dividends from two consolidated subsidiaries of the Company. As a result, there will be an impact on the Company's non-consolidated financial results, as announced below.

1. Outline

  • (1) Date of receipt of dividends: March 27, 2023

  • (2) Amount of dividends:

Company Name

Amount of Dividends

TEIJIN PHARMA LIMITED

¥24,000 million

TEIJIN FRONTIER CO., LTD.

¥4,500 million

2. Impact on Financial Results

As a result of the receipt of these dividends, the Company will record the dividends income of ¥28,500 million as non-operating income in its non-consolidated financial results for FY2022, the fiscal year ending March 31, 2023.

There will be no impact on the consolidated financial results for FY2022, as these dividends are from consolidated subsidiaries.

- End -

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Teijin Limited published this content on 27 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 March 2023 08:37:09 UTC.